Search research articles
Contact Us
Filters
Showing results (101-110 of 142) with videos related to
Page
of 15
Sort By:
International Journal of Cancer
|
July 22, 2014
Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells
Florence Deauvieau, Vincent Ollion, Anne-Claire Doffin, et al.
Oncoimmunology
|
June 28, 2024
Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients
Stéphane Dalle, Estelle Verronese, Axelle N'Kodia, et al.
Cancer Research
|
May 16, 2015
Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes
Cristina Ghirelli, Fabien Reyal, Marine Jeanmougin, et al.
Nature Communications
|
June 4, 2020
Durable and controlled depletion of neutrophils in mice
Gael Boivin, Julien Faget, Pierre-Benoit Ancey, et al.
Journal of Innate Immunity
|
June 23, 2025
TLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence
Emily Sible, Gregory Weitsman, Salome Amouyal, et al.
Stem Cell Reports
|
January 21, 2015
Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response
Marion Chapellier, Elodie Bachelard-Cascales, Xenia Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patients
Julien Péron, Claire Cropet, Olivier Tredan, et al.
Therapeutic Advances in Medical Oncology
|
August 11, 2025
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy
Olivia Le Saux, Renaud Sabatier, Isabelle Treilleux, et al.
Journal for Immunotherapy of Cancer
|
November 8, 2023
MDR1-EXPRESSING CD4<sup>+</sup> T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE
Anthony Di Roio, Margaux Hubert, Laurie Besson, et al.
Science Immunology
|
April 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Margaux Hubert, Elisa Gobbini, Coline Couillault, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 142) with videos related to
Sort By:
Page
of 15
International Journal of Cancer
|
July 22, 2014
Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells
Florence Deauvieau, Vincent Ollion, Anne-Claire Doffin, et al.
Oncoimmunology
|
June 28, 2024
Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients
Stéphane Dalle, Estelle Verronese, Axelle N'Kodia, et al.
Cancer Research
|
May 16, 2015
Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes
Cristina Ghirelli, Fabien Reyal, Marine Jeanmougin, et al.
Nature Communications
|
June 4, 2020
Durable and controlled depletion of neutrophils in mice
Gael Boivin, Julien Faget, Pierre-Benoit Ancey, et al.
Journal of Innate Immunity
|
June 23, 2025
TLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence
Emily Sible, Gregory Weitsman, Salome Amouyal, et al.
Stem Cell Reports
|
January 21, 2015
Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response
Marion Chapellier, Elodie Bachelard-Cascales, Xenia Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 19, 2012
CD4 lymphopenia to identify end-of-life metastatic cancer patients
Julien Péron, Claire Cropet, Olivier Tredan, et al.
Therapeutic Advances in Medical Oncology
|
August 11, 2025
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy
Olivia Le Saux, Renaud Sabatier, Isabelle Treilleux, et al.
Journal for Immunotherapy of Cancer
|
November 8, 2023
MDR1-EXPRESSING CD4<sup>+</sup> T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE
Anthony Di Roio, Margaux Hubert, Laurie Besson, et al.
Science Immunology
|
April 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Margaux Hubert, Elisa Gobbini, Coline Couillault, et al.
Page
of 15